Paul Robert Hinton

This inventor holds 21 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Antibody Engineering. Top assignees: Pdl Biopharma, Inc., Abbvie Inc., Facet Biotech Corporation. Active years: 2006-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Robert Hinton. Retrieved from https://idiyas.com/inventor/paul-robert-hinton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 15)

% Patents Active = 71.4

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 4.1

ph-index = 12

Forward Citations = 630(Granted Patents)

Location History:

Fremont, CA (US) (2006)
Sunnyvale, CA (US) (2006 - 2022)

Company Filing History:

Facet Biotech Corporation

patents

4. 3 out of 71

Progenics Pharmaceuticals, Inc.

patents

5. 2 out of 4,190

Abbott Laboratories Corporation

patents

6. 2 out of 52

Abbvie Biotherapeutics Inc.

Eli Lilly and Company

patents

9. 1 out of 392

Genetics Institute, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2022

Loading Chart...

Areas of Expertise:

Interleukin-13 Binding Proteins

Fc Variants

Humanized Antibodies

Anti-CCR5 Antibody

IL-12/p40 Binding Proteins

Cytotoxicity Mediation

FcRn Binding Affinities

Amphiregulin Antibodies

CTLA4 Antibodies

Serum Half-Lives

Mutagenesis

Complement Activation

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11344621 - Interleukin-13 binding proteins (2022-05-31),

2. 10150814 - Fc variants with improved complement activation (2018-12-11),

3. 10086076 - Interleukin-13 binding proteins (2018-10-02),

4. 9592293 - Interleukin-13 binding proteins (2017-03-14),

5. 8629257 - IL-12/p40 binding proteins (2014-01-14),

6. 8624007 - Alteration of Fc-fusion protein serum half-lives by mutagenesis (2014-01-07),

7. 8604177 - Interleukin-13 binding proteins (2013-12-10),

8. 7915388 - Interleukin-13 binding proteins (2011-03-29),

9. 7851600 - Anti-CCR5 antibody (2010-12-14),

10. 7732570 - Alteration of Fc-fusion protein serum half-lives by mutagenesis (2010-06-08),

11. 7700739 - IL-12/p40 binding proteins (2010-04-20),

12. 7666419 - Anti-CCR5 antibody (2010-02-23),

13. 7442777 - Cytotoxicity mediation of cells evidencing surface expression of CD63 (2008-10-28),

14. 7365168 - Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis (2008-04-29),

15. 7361740 - Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis (2008-04-22),

Title: The Innovative Journey of Paul Robert Hinton

Introduction: Paul Robert Hinton, a visionary inventor based in Sunnyvale, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Paul Robert Hinton's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach to innovation.

Career Highlights: With a career spanning over two decades, Paul Robert Hinton has established himself as a leading figure in the tech industry, having worked with renowned companies such as Google X and Tesla. His innovative solutions have revolutionized various sectors, earning him recognition as a pioneer in his field.

Collaborations: Throughout his career, Paul Robert Hinton has collaborated with top research institutions and universities to further advance the boundaries of technology. His partnerships with leading experts have led to the development of groundbreaking inventions that have reshaped industries.

Conclusion: Paul Robert Hinton's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his reputation as a trailblazing inventor. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.